Actelion Pharmaceuticals Ltd - Strategic SWOT Analysis Review

September 2021 | 28 pages | ID: A2E22502C95EN
GlobalData

Abstracts

Actelion Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Actelion Pharmaceuticals Ltd (Actelion), a subsidiary of Johnson & Johnson, is a biopharmaceutical company, which discovers, develops and commercializes innovative treatments for diseases with considerable unmet medical needs. The company focuses on the development of treatments for pulmonary arterial hypertension (PAH). Its PAH franchise products include Tracleer (bosentan), Opsumit (macitentan), Veletri (epoprostenol for injection), Ventavis (iloprost) and Uptravi (selexipag). Its specialty product includes Zavesca (miglustat). Actelion also offers approved treatments for diseases including Type 1 Gaucher disease, Niemann-Pick type C disease, multiple sclerosis and digital ulcers in patients with systemic sclerosis. The company offers its products in various countries across Europe, besides Japan, China, Russia, and the US, among others. Actelion is headquartered in Allschwil, Switzerland.

Actelion Pharmaceuticals Ltd Key Recent Developments

Sep 15,2021: Owkin enters into agreement to build innovative methods with the potential to enhance AI-enabled external control arms

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Actelion Pharmaceuticals Ltd - Key Facts
Actelion Pharmaceuticals Ltd - Key Employees
Actelion Pharmaceuticals Ltd - Key Employee Biographies
Actelion Pharmaceuticals Ltd - Major Products and Services
Actelion Pharmaceuticals Ltd - History
Actelion Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Actelion Pharmaceuticals Ltd - Business Description
Actelion Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
Actelion Pharmaceuticals Ltd - Strengths
Actelion Pharmaceuticals Ltd - Weaknesses
Actelion Pharmaceuticals Ltd - Opportunities
Actelion Pharmaceuticals Ltd - Threats
Actelion Pharmaceuticals Ltd - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Actelion Pharmaceuticals Ltd, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Sep 15, 2021: Owkin enters into agreement to build innovative methods with the potential to enhance AI-enabled external control arms

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Actelion Pharmaceuticals Ltd, Key Facts
Actelion Pharmaceuticals Ltd, Key Employees
Actelion Pharmaceuticals Ltd, Key Employee Biographies
Actelion Pharmaceuticals Ltd, Major Products and Services
Actelion Pharmaceuticals Ltd, History
Actelion Pharmaceuticals Ltd, Subsidiaries
Actelion Pharmaceuticals Ltd, Key Competitors
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Actelion Pharmaceuticals Ltd, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Actelion Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021